Japanese study shows that Ivermectin has antiviral effect on COVID-19 Omicron variant – The Published Reporter®

dr.  paul marik
Paul Marik, MD, a highly respected physician, was recently forced to resign from his position as Chief of Critical Care at Eastern Virginia Medical School due to his struggle to be able to use Ivermectin to treat his patients. Marik has noted the Ivermectin studies in Japan, the UK and other countries and said similar research should be conducted in the US. File photo: Front Line COVID-19 Critical Care Alliance via EINPresswire.

WASHINGTON, DC – A study conducted in Japan has shown that the antiparasitic drug Ivermectin has produced a “anti-viral” effect on the Omicron COVID-19 variant – and also other variants – despite the Food and Drug Administration (FDA) previously warning against the use of the drug to treat COVID.

On Monday, the Japanese trading and pharmaceutical company Kowa Co. revealed. Ltd., in collaboration with Tokyo’s Kitasato University, the results of their study, in which they stated that Ivermectin was found to be useful for the treatment of COVID-19 variants in joint laboratory-based non-clinical research, but did not provide further details.

Kowa representatives noted that clinical trials are still ongoing on the effectiveness of Ivermectin, saying that so far it has “same antiviral effect” on all “mutant strains” of the virus.

In addition, the University of Oxford in the UK has also announced a clinical trial to investigate Ivermectin as a COVID-19 treatment, but researchers noted on Monday that it was still early and would not issue statements until they have more concrete results to report. .

United Patriot

Previous promotion of Ivermectin as an alternative COVID treatment has been the subject of much controversy.

Ivermectin has been used for decades to effectively treat parasitic infections in humans; However, the FDA has not approved its use to treat the virus, and as a result, it is not covered by federal COVID-19 funding at U.S. hospitals, which only go to approved treatments.

“The FDA has not approved or has approved ivermectin for the treatment or prevention of COVID-19 in humans or animals. Ivermectin has not been shown to be safe or effective for these indications,” the FDA website states. Uses may interact with other drugs, such as blood thinners. You can also overdose ivermectin, which can cause nausea, vomiting, diarrhea, hypotension (low blood pressure), allergic reactions (itching and hives), dizziness, ataxia (balance problems), seizures, coma and even death.

Dr. However, Paul Marik has been a staunch supporter of using Ivermectin to counter COVID, and was recently forced to resign from his position at Eastern Virginia Medical School due to his struggle to use the drug to treat his patients.

Marik has taken note of the Ivermectin studies in Japan, the UK and other countries and said that similar research should be conducted in the US

“Ivermectin is one of the safest drugs on this planet’s face,” he said. “So somehow Japanese, Native Americans, Brazilian people can tolerate it for sure, but it’s toxic in Americans. You have to make fun of it.”

Leave a Comment